- Global Pharma News & Resources

Global Stereotactic Surgery Devices Market Size, Share & Trends Analysis Report, 2018-2025 with Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray Dominating

Global Stereotactic Surgery Devices Market Size, Share & Trends Analysis Report, 2018-2025 with Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray Dominating

PR Newswire

DUBLIN, Aug. 23, 2018

DUBLIN, Aug. 23, 2018 /PRNewswire/ --

The "Stereotactic Surgery Devices Market Size, Share & Trends Analysis Report By Type (Gamma Knife, Linear Accelerator, CyberKnife, Proton Beam Therapy), By Region, And Segment Forecasts, 2018 - 2025" report has been added to's offering.

The global stereotactic surgery devices market size is expected to reach USD 25.9 billion by 2025, expanding at a CAGR of 6.1% during the forecast period

Stereotactic surgery is a minimally invasive alternative for traditional invasive ablation and biopsy methods. Since, stereotactic surgery has various advantages such as higher efficacy, minimal or no surgical incisions, and lower risk of damage to healthy cells, it is replacing conventional radiotherapies. These surgical procedures have helped overcome drawbacks associated with traditional invasive surgeries, such as destruction of healthy cells and higher risk of recurrence & postoperative complications.

Only around 10.0% of the population in low and middle-income countries have access to radiation therapy, owing to dearth of radiation therapy devices. A market leader, Elekta, in its 2016 annual report stated that the number of installations of linear accelerators in high-income countries was approximately 13,000, whereas the requirement was around 25,000. Hence, huge demand-supply discrepancy of radiotherapy devices is likely to open new avenues for major market players in developing countries.

Further key findings from the study suggest:

  • Linear accelerators (LINAC) accounted for the leading volume share in 2017, owing to higher affordability and larger commercial availability
  • CyberKnife is poised to exhibit the fastest growth over the forecast period owing to their growing adoption in developing countries
  • North America dominated the market in 2017 due to number of government initiatives focused on creating awareness regarding availability of advanced treatment options and presence of developed healthcare infrastructure
  • Some of the major players operating in the market are Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray Incorporated
  • These players dominate the market with their strong brand identity and extensive geographical reach attained through various strategic initiatives such as mergers & acquisitions and partnership agreements.

Key Topics Covered:

Chapter 1 Report Scope
1.1 Market Segmentation and Scope
1.2 Regional Segmentation and Scope

Chapter 2 Research Methodology
2.1 Information procurement
2.2 Data Analysis
2.3 Approaches for market estimation
2.3.1 Approach 1: Demand Analysis & Bottom up Approach
2.3.2 Approach 2: Top down market estimation
2.3.3 Approach 3: Commodity flow and bottom up market estimation
2.3.4 Approach 4: KoL perspective based market sizing

Chapter 3 Objective

Chapter 4 Executive Summary
4.1 Market Snapshot

Chapter 5 Market Definitions
5.1 Segment Definitions
5.1.1 Technology Type Gamma Knife Linear Accelerator Particle Beam CyberKnife

Chapter 6 Industry Outlook
6.1 Business Segment Trends
6.1.1 Technology business analysis
6.1.2 Regional business analysis
6.2 Market Variable Analysis
6.2.1 Market Driver Analysis
6.2.2 Market Restraint Analysis
6.3 Business Environment Analysis Tools
6.3.1 Penetration & growth prospect mapping
6.3.2 Stereotactic Surgery Devices Market - SWOT Analysis, By Factor (political & legal, economic and technological)
6.3.3 Stereotactic Surgery Devices: Industry Analysis - Porter's
6.3.4 Value Chain Analysis

Chapter 7 Stereotactic Surgery Devices Market: Product Estimates & Trend Analysis
7.1 Stereotactic Surgery Devices Market Product Type Outlook Key Takeaways
7.2 Stereotactic Surgery Devices Market: Product Type Movement Analysis
7.3 Gamma Knife
7.3.1 Gamma knife market, 2014 - 2025 (USD Million)
7.4 Linear Accelerators (LINAC)
7.4.1 LINAC market, 2014 - 2025 (USD Million)
7.5 Proton Beam Therapy
7.5.1 Proton beam therapy market, 2014 - 2025 (USD Million)
7.6 CyberKnife
7.6.1 Cyberknife market, 2014 - 2025 (USD Million)

Chapter 8 Stereotactic Surgery Devices Market: Regional Estimates & Trend Analysis, by Product Type

Chapter 9 Competitive Landscape

  • AstraZeneca
  • Bayer AG
  • Merck KGaA
  • Abbott
  • Pfizer, Inc.
  • Sanofi
  • Bristol Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Ferring B.V.

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content with multimedia:

SOURCE Research and Markets

Editor Details

Last Updated: 23-Aug-2018